1. Goldin，A. L.，et al. Nomenclature of voltage-gated sodium channels.Neuron，2000.28（2）：365-368.

2. Dubois，J.M.，C.Bergman.Late sodium current in the node of Ranvier.Pflugers Arch，1975，357（1-2）：145-148.

3. Clancy，C.E.，et al.Non-equilibrium gating in cardiac Na+ channels：an original mechanism of arrhythmia.Circulation，2003，107（17）：2233-2237.

4. Kiyosue，T.M.Arita.Late sodium current and its contribution to action potential configuration in guinea pig ventricular myocytes.Circ Res，1989，64（2）：389-397.

5. Grandi E.，et al.Simulation of Ca-calmodulin-dependent protein kinase II on rabbit ventricular myocyte ion currents and action potentials.Biophys J，2007，93（11）：3835-3847.

6. Maltsev，V.A.，A.I.Undrovinas，A multi-modal composition of the late Na+ current in human ventricular cardiomyocytes. Cardiovasc Res，2006，69（1）：116-127.

7. Marangoni S.，et al. A Brugada syndrome mutation（p. S216L）and its modulation by p. H558R polymorphism：standard and dynamic characterization. Cardiovasc Res，2011，91（4）：606-616.

8. Maltsev，V.A.，J.W.Kyle，A.Undrovinas.Late Na+ current produced by human cardiac Na+ channel isoform Nav 1. 5 is modulated by its beta1 subunit.J Physiol Sci，2009，59（3）：217-225.

9. Yong S.L.，et al.Characterization of the cardiac sodium channel SCN5A mutation，N1325S，in single murine ventricular myocytes.Biochem Biophys Res Commun，2007，352（2）：378-383.

10. Zhang T.，et al.LQTS mutation N1325S in cardiac sodium channel gene SCN5A causes cardiomyocyte apoptosis，cardiac fibrosis and contractile dysfunction in mice.Int J Cardiol，2011，147（2）：239-245.

11. Undrovinas，A.and V.A.Maltsev，Late sodium current is a new therapeutic target to improve contractility and rhythm in failing heart. Cardiovasc Hematol Agents Med Chem，2008，6（4）：348-359.

12. Valdivia，C.R.，et al.Increased late sodium current in myocytes from a canine heart failure model and from failing human heart.J Mol Cell Cardiol，2005，38（3）：475-483.

13. Houser，S.R.Can novel therapies for arrhythmias caused by spontaneous sarcoplasmic reticulum Ca2+ release be developed using mouse models？Circ Res，2005，96（10）：1031-1032.

14. Bers，D.M.，W.H.Barry and S.Despa，Intracellular Na+ regulation in cardiac myocytes.Cardiovasc Res，2003，57（4）：897-912.

15. Chaitman，B.R.Ranolazine for the treatment of chronic angina and potential use in other cardiovascular conditions.Circulation，2006，113（20）：2462-2472.

16. Grandi E.，et al. Simulation of Ca-calmodulin-dependent protein kinase II on rabbit ventricular myocyte ion currents and action potentials.Biophys J，2007，93（11）：3835-3847.

17. Yao L.，et al.Nav1.5-dependent persistent Na+ influx activates CaMKII in rat ventricular myocytes and N1325S mice. Am J Physiol Cell Physiol，2011，301（3）：C577-586.

18. Maier，L.S.A novel mechanism for the treatment of angina，arrhythmias，and diastolic dysfunction：inhibition of late I （Na）using ranolazine. J Cardiovasc Pharmacol，2009，54（4）：279-286.

19. Maltsev，V.A.，et al.Modulation of late sodium current by Ca2+，calmodulin，and CaMKII in normal and failing dog cardiomyocytes：similarities and differences. Am J Physiol Heart Circ Physiol，2008，294（4）：H1597-608.

20. Moreno，J.D.，C.E.Clancy.Pathophysiology of the cardiac late Na current and its potential as a drug target.J Mol Cell Cardiol，2012，52（3）：608-619.

21. Zaza A.，M. Rocchetti. The late Na + current--origin and pathophysiological relevance.Cardiovasc Drugs Ther，2013，27（1）：61-68.

22. Rocchetti M.，et al.Ranolazine prevents INaL enhancement and blunts myocardial remodelling in a model of pulmonary hypertension.Cardiovasc Res，2014，104（1）：37-48.

23. Pastore，J.M.，et al.Mechanism linking T-wave alternans to the genesis of cardiac fibrillation. Circulation，1999，99 （10）：1385-1394.

24. Weiss，J.N.，et al.Alternans and arrhythmias：from cell to heart.Circ Res，2011，108（1）：98-112.

25. Lyon，A.R.，et al.Loss of T-tubules and other changes to surface topography in ventricular myocytes from failing human and rat heart.Proc Natl Acad Sci U S A，2009，106 （16）：6854-6859.

26. Wei，S.，et al. T-tubule remodeling during transition from hypertrophy to heart failure.Circ Res，2010，107（4）：520-531.

27. Aistrup，G.L.，et al. Inhibition of the late sodium current slows t-tubule disruption during the progression of hypertensive heart disease in the rat.Am J Physiol Heart Circ Physiol，2013，305（7）：H1068-1079.

28. Belardinelli，L.，et al.A novel，potent，and selective inhibitor of cardiac late sodium current suppresses experimental arrhythmias.J Pharmacol Exp Ther，2013，344（1）：23-32.

29. Saint D.A.The cardiac persistent sodium current：an appealing therapeutic target？Br J Pharmacol，2008，153（6）：1133-1142.

30. Antzelevitch C.et al.Electrophysiologic basis for the antiarrhythmic actions of ranolazine.Heart Rhythm，2011，8（8）：1281-1290.

31. Antzelevitch C.，et al.Electrophysiologic properties and antiarrhythmic actions of a novel antianginal agent.J Cardiovasc Pharmacol Ther，2004，9 Suppl 1：S65-83.

32. Tavazzi L.Ranolazine，a new antianginal drug.Future Cardiol，2005，1（4）：447-455.

33. Fish J.M.，et al.Epicardial activation of left ventricular wall prolongs QT interval and transmural dispersion of repolarization：implications for biventricular pacing. Circulation，2004，109（17）：2136-2142.

34. Reddy B. M.，H. S. Weintraub，A. Z. Schwartzbard. Ranolazine：a new approach to treating an old problem.Tex Heart Inst J，2010，37（6）：641-647.

35. Chevalier，M.，et al.Late cardiac sodium current can be assessed using automated patch-clamp. F1000Res，2014，3：245.

36. Ulbricht，W.Effects of veratridine on sodium currents and fluxes.Rev Physiol Biochem Pharmacol，1998，133：1-54.

37. Shryock，J.C.，et al.The arrhythmogenic consequences of increasing late INa in the cardiomyocyte. Cardiovasc Res，2013，99（4）：600-611.

38. Yang，T.，et al.Screening for acute IKr block is insufficient to detect torsades de pointes liability：role of late sodium current.Circulation，2014，130（3）：224-234.

39. Pezhouman A.，et al.Selective inhibition of late sodium current suppresses ventricular tachycardia and fibrillation in intact rat hearts.Heart Rhythm，2014，11（3）：492-501.

40. Bonatti R.，et al.Selective late sodium current blockade with GS-458967 markedly reduces ischemia-induced atrial and ventricular repolarization alternans and ECG heterogeneity. Heart Rhythm，2014，11（10）：1827-1835.